Jens Jensenius
8Patents
6h-index
4Co-inventors
56Inventor score
Filing activity: Dec 8, 1986 → Mar 27, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6562784B1 | Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals | Chemistry; Metallurgy | 35 | Expired |
| US6846649B1 | Recombinant human mannan-binding lectin | Chemistry; Metallurgy | 32 | Expired |
| US7202207B2 | Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals | Chemistry; Metallurgy | 22 | Expired |
| US7439224B2 | Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals | Chemistry; Metallurgy | 21 | Active |
| US7112414B2 | Masp-2, a complement-fixing enzyme, and uses for it | Physics | 19 | Expired |
| US5338661A | Monoclonal antibody specific for a human tumour-associated antigen | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4906734A | Human conglutinin | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5132287A | Methods of treating disorders which cause conglutinin deficiency | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.